Detalles de la búsqueda
1.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
; 594(7863): 418-423, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33953400
2.
FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
Eur Radiol
; 33(3): 1746-1756, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114846
3.
Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer.
Int J Cancer
; 150(12): 2038-2045, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179785
4.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
N Engl J Med
; 381(17): 1632-1643, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566309
5.
Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice.
Cancer Control
; 29: 10732748221096842, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35475677
6.
Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions for determining TME quality.
Int J Colorectal Dis
; 37(6): 1289-1300, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513539
7.
Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.
Cancer Sci
; 112(11): 4669-4678, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34327766
8.
A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer.
Invest New Drugs
; 39(5): 1335-1347, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33829355
9.
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Oncologist
; 25(3): e502-e511, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162799
10.
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.
Invest New Drugs
; 38(6): 1696-1706, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32462369
11.
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
J Cancer Educ
; 35(3): 545-556, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820925
12.
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
Invest New Drugs
; 37(4): 763-770, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536151
13.
3'-Deoxy-3'-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies.
Eur J Nucl Med Mol Imaging
; 46(8): 1713-1722, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31041456
14.
Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.
BMC Cancer
; 19(1): 404, 2019 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035949
15.
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Br J Cancer
; 118(9): 1169-1175, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29576622
16.
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors.
Oncologist
; 23(2): 155-e17, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158363
17.
Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer.
World J Surg
; 42(7): 2227-2233, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29282505
18.
Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience.
Chin J Cancer Res
; 30(4): 460-467, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30210226
19.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Oncologist
; 22(3): 293-303, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209749
20.
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Ann Surg Oncol
; 24(5): 1289-1294, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853901